Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 10.67M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -22.26M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | - |
| Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -26.00% |
| Dividend | N/A | Price/Book | 0.09 | EPS next 5Y | - | 52W High Chg | -49.00% |
| Recommedations | - | Quick Ratio | 0.26 | Shares Outstanding | 169.13M | 52W Low Chg | - |
| Insider Own | 17.12% | ROA | -0.94% | Shares Float | 138.75M | Beta | 0.29 |
| Inst Own | - | ROE | -28.86% | Shares Shorted/Prior | -/- | Price | 0.04 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | - | Target Price | - |
| Oper. Margin | - | Earnings Date | - | Volume | 1,165 | Change | 0.00% |
About QUEST PHARMATECH INC
Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer. In addition, it develops, manufactures, and commercializes immunotherapy products for pancreatic cancer; and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.
QUEST PHARMATECH INC News